BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38848354)

  • 1. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
    Bansal P; Banda EC; Glatt-Deeley HR; Stoddard CE; Linsley JW; Arora N; Deleschaux C; Ahern DT; Kondaveeti Y; Massey RE; Nicouleau M; Wang S; Sabariego-Navarro M; Dierssen M; Finkbeiner S; Pinter SF
    Sci Adv; 2024 Jun; 10(23):eadj0385. PubMed ID: 38848354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing Trisomy 21 with XIST in Neural Stem Cells Promotes Neuronal Differentiation.
    Czermiński JT; Lawrence JB
    Dev Cell; 2020 Feb; 52(3):294-308.e3. PubMed ID: 31978324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
    Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
    Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
    Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
    Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trisomy correction in Down syndrome induced pluripotent stem cells.
    Li LB; Chang KH; Wang PR; Hirata RK; Papayannopoulou T; Russell DW
    Cell Stem Cell; 2012 Nov; 11(5):615-9. PubMed ID: 23084023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
    Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
    Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling.
    Moon JE; Lawrence JB
    Cell Rep; 2022 Aug; 40(6):111174. PubMed ID: 35947952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy silencing by XIST normalizes Down syndrome cell pathogenesis demonstrated for hematopoietic defects in vitro.
    Chiang JC; Jiang J; Newburger PE; Lawrence JB
    Nat Commun; 2018 Dec; 9(1):5180. PubMed ID: 30518921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating dosage compensation to trisomy 21.
    Jiang J; Jing Y; Cost GJ; Chiang JC; Kolpa HJ; Cotton AM; Carone DM; Carone BR; Shivak DA; Guschin DY; Pearl JR; Rebar EJ; Byron M; Gregory PD; Brown CJ; Urnov FD; Hall LL; Lawrence JB
    Nature; 2013 Aug; 500(7462):296-300. PubMed ID: 23863942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
    Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
    Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation changes in Down syndrome derived neural iPSCs uncover co-dysregulation of ZNF and HOX3 families of transcription factors.
    Laan L; Klar J; Sobol M; Hoeber J; Shahsavani M; Kele M; Fatima A; Zakaria M; Annerén G; Falk A; Schuster J; Dahl N
    Clin Epigenetics; 2020 Jan; 12(1):9. PubMed ID: 31915063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
    Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
    Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
    Kurabayashi N; Sanada K
    Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficits in human trisomy 21 iPSCs and neurons.
    Weick JP; Held DL; Bonadurer GF; Doers ME; Liu Y; Maguire C; Clark A; Knackert JA; Molinarolo K; Musser M; Yao L; Yin Y; Lu J; Zhang X; Zhang SC; Bhattacharyya A
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9962-7. PubMed ID: 23716668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.
    Alexandrov PN; Percy ME; Lukiw WJ
    Cell Mol Neurobiol; 2018 Apr; 38(3):769-774. PubMed ID: 28687876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive investigation of DNA methylation and gene expression in trisomy 21 placenta.
    Lim JH; Kim SY; Han JY; Kim MY; Park SY; Ryu HM
    Placenta; 2016 Jun; 42():17-24. PubMed ID: 27238709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21.
    Gonzales PK; Roberts CM; Fonte V; Jacobsen C; Stein GH; Link CD
    PLoS One; 2018; 13(3):e0194581. PubMed ID: 29584757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21.
    Toshikawa H; Ikenaka A; Li L; Nishinaka-Arai Y; Niwa A; Ashida A; Kazuki Y; Nakahata T; Tamai H; Russell DW; Saito MK
    Sci Rep; 2021 Aug; 11(1):17377. PubMed ID: 34462463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
    Kahlem P; Sultan M; Herwig R; Steinfath M; Balzereit D; Eppens B; Saran NG; Pletcher MT; South ST; Stetten G; Lehrach H; Reeves RH; Yaspo ML
    Genome Res; 2004 Jul; 14(7):1258-67. PubMed ID: 15231742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.